| Good morning Wake-Up Watchlisters! While you're sipping coffee you'll see US stock futures fell on Thursday. Investors are assessing whether the economy will hold up in all these worst-case recession scenarios. Chipmaker Micron also reported a gloomy outlook (more on that below). If it's time for 'America's Reckoning' in 2023, it's crucial to know where to put your money. Right now our Head Fundamental Tactician Karim Rahemtulla is showing traders a $3 alternative asset that could be the play in a potentially rough 2023. Click here to discover this unique $3 strategy. Here's a look at the top-moving stocks this morning. Mirati Therapeutics (Nasdaq: MRTX) Mirati Therpeutics is up 10.68% premarket after receiving breakthrough therapy designation from the FDA for patients with advanced colorectal cancer. The designation is supported by results from a Phase 11b cohort of the KRYSTAL-1 trial. The FDA will now grant to expedite the development and regulatory review of the drug. It's been a strong last couple of weeks for the medical sector. Our friend Alexander Green is also high on another medical stock. This company has the patent on a medical device that could be the biggest breakthrough in 37 years – and it's trading for under $3 right now. Click here to unlock this stock. CarMax (NYSE: KMX) CarMax is down 14.13% premarket after a big earnings miss. The company cited 'vehicle affordability challenges' due to inflation and rising interest rates. Net income from the quarter to Nov. 30 fell to $37.6 million, or 24 cents a share, from $269.4 million, or $1.63 a share, in the year-ago period. Earnings reports are often big catalysts in determining whether a stock will go up or down. Our Head Fundamental Tactician uses his Insider Matrix to track where the big guns are putting their money – and this strategy could lead to big moves on earnings day. Click here to learn more about the Insider Matrix. | 
No comments:
Post a Comment